tiprankstipranks
Santen Pharmaceutical Co. Reports Mixed Financial Results
Company Announcements

Santen Pharmaceutical Co. Reports Mixed Financial Results

Santen Pharmaceutical Co (JP:4536) has released an update.

Don't Miss Our Christmas Offers:

Santen Pharmaceutical Co. reported a slight revenue increase of 0.4% for the six months ending September 2024, but faced declines in core operating profit and net profit by 5.7% and 10.3% respectively. Despite these challenges, the company plans to maintain its dividend payouts, signaling confidence in its long-term financial health.

For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Japan Auto-Generated NewsdeskSanten Pharmaceutical Completes Strategic Share Buyback
TipRanks Japan Auto-Generated NewsdeskSanten Pharmaceutical’s Strategic Share Buyback Update
TheFlyClearside Biomedical’s partner signed new collaboration agreement with Santen
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App